Core Laboratories (CLB) FCF Margin (2022 - 2026)
Core Laboratories filings provide 5 years of FCF Margin readings, the most recent being 2.04% for Q1 2026.
- On a quarterly basis, FCF Margin fell 110.0% to 2.04% in Q1 2026 year-over-year; TTM through Mar 2026 was 4.66%, a 385.0% decrease, with the full-year FY2025 number at 4.9%, down 359.0% from a year prior.
- FCF Margin hit 2.04% in Q1 2026 for Core Laboratories, down from 3.62% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 15.87% in Q4 2022 to a low of 2.93% in Q3 2023.
- Median FCF Margin over the past 5 years was 3.48% (2025), compared with a mean of 5.38%.
- Biggest five-year swings in FCF Margin: soared 1064bps in 2024 and later tumbled -983bps in 2025.
- Core Laboratories' FCF Margin stood at 15.87% in 2022, then decreased by -4bps to 15.21% in 2023, then decreased by -12bps to 13.44% in 2024, then plummeted by -73bps to 3.62% in 2025, then crashed by -44bps to 2.04% in 2026.
- The last three reported values for FCF Margin were 2.04% (Q1 2026), 3.62% (Q4 2025), and 0.79% (Q3 2025) per Business Quant data.